Table 5 Dynamic CA parameters in stroke and control participants by geographical region
Variables | Stroke Patients | Controls | ||||
|---|---|---|---|---|---|---|
SP (n = 25) | LEI (n = 25) | SP (n = 25) | LEI (n = 25) | |||
AH | UH | AH | UH | |||
Coherence VLF range | 0.65 (0.19) | 0.64 (0.14) | 0.61 (0.14) | 0.59 (0.14) | 0.52 (0.16) | 0.48 (0.11) |
Coherence LF range | 0.68 (0.23)# | 0.73 (0.19)# | 0.68 (0.17)# | 0.71 (0.15)# | 0.56 (0.18) | 0.58 (0.15) |
Coherence HF range | 0.72 (0.18)# | 0.77 (0.10)# | 0.69 (0.17)# | 0.67 (0.16)# | 0.52 (0.21) | 0.51 (0.15) |
Normalized gain VLF range, % mm Hg− 1 | 1.26 (0.57) | 1.17 (0.66) | 0.94 (0.33) | 0.91 (0.34) | 1.01 (0.39) | 1.19 (0.43) |
Normalized gain LF range, % mm Hg− 1 | 1.32 (0.48) | 1.22 (0.46) | 1.35 (0.44) | 1.26 (0.69) | 1.45 (0.83) | 1.49 (0.78) |
Normalized gain HF range, % mm Hg− 1 | 1.50 (0.74)* | 1.36 (0.51) | 1.36 (0.54) | 1.28 (0.55) | 1.35 (0.63) | 1.40 (0.58) |
Phase VLF range, radians | 0.53 (0.42)# | 0.78 (0.39)# | 0.58 (0.50)# | 0.70 (0.49)# | 0.88 (0.35) | 0.87 (0.41) |
Phase LF range, radians | 0.30 (0.45) | 0.25 (0.38) | 0.30 (0.35) | 0.31 (0.39) | 0.48 (0.19) | 0.45 (0.41) |
Phase HF range, radians | 0.09 (0.29) | 0.10 (0.25) | 0.11 (0.40)# | 0.17 (0.21)# | 0.05 (0.21) | 0.01 (0.28) |
ARI | 4.8 (2.3)# | 4.9 (2.0)# | 5.1 (1.8)# | 5.0 (1.1)# | 5.9 (1.5) | 5.5 (1.2) |